Accès à distance ? S'identifier sur le proxy UCLouvain
Safety of combination of methotrexate (MTX) and infliximab (IFX) in a large Belgian observational patient cohort with refractory rheumatoid arthritis.
Primary tabs
| Document type | Communication à un colloque (Conference Paper) – Abstract, Présentation orale avec comité de sélection |
|---|---|
| Publication date | 2002 |
| Language | Anglais |
| Conference | "66th Annual Scientific Meeting of the American-College-of-Rheumatology/37th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals", NEW ORLEANS (Louisiana) (Oct 24-29, 2002) |
| Journal information | "Arthritis & Rheumatism" - Vol. 46, no. 9, p. S536-S536 (2002) |
| Peer reviewed | yes |
| issn | 0004-3591 |
| e-issn | 1529-0131 |
| Publisher | Wiley-liss (New York) |
| Affiliation | UCL |
| Links |
| Bibliographic reference | Durez, Patrick ; Vandenbosch, F. ; Corluy, L ; Van den Bossche, N ; Schuerwegh, A ; et. al. Safety of combination of methotrexate (MTX) and infliximab (IFX) in a large Belgian observational patient cohort with refractory rheumatoid arthritis..66th Annual Scientific Meeting of the American-College-of-Rheumatology/37th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals (NEW ORLEANS (Louisiana), Oct 24-29, 2002). In: Arthritis & Rheumatism, Vol. 46, no. 9, p. S536-S536 (2002) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/61550 |